Tumorzentrum der Universität Erlangen-Nürnberg

Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer (2026) Van Mackelenbergh MT, Pfarr N, Weber K, Untch M, Solbach C, Schneeweiss A, Jank P, et al. Journal article Modeling hospital catchment areas in pediatric oncology using an empirically parameterized extended Huff-model (2026) Kapitza J, Wieland T, Metzler M Journal article Microdochectomy for patients with nipple discharge and the risk of associated breast cancer (2026) Amann N, Gökce Z, Hack CC, Seitz K, Eckstein S, Hörner M, Geppert CC, et al. Journal article Physiologically-Based Pharmacokinetics of Ribociclib Drug–Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast Cancer (2026) Ji Y, Huth F, Wang C, Schiller H, Combes FP, Crown J, Fasching P, et al. Journal article HIF sustain a transcriptional regulatory circuit of EPAS1 expression in renal clear cell carcinoma (2026) Naas S, Krüger R, Grampp S, Lauer V, Kraus A, Naas J, Müller F, et al. Journal article SMARCA4-deficient carcinoma of the head and neck region: report of 8 new sinonasal and non-sinonasal cases and literature review (2026) Farkas M, Agaimy A, Švajdler M, Hauer L, Martínek P, Vaněček T, Pivovarčíková K, et al. Journal article Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study (2026) Kuemmel S, Fasching P, Schmid P, Harbeck N, Takahashi M, Untch M, Boileau JF, et al. Journal article Registry Study of the Working Group on Cervical Pathology and Colposcopy (AGCPC) on the Diagnostic Algorithm for the New Cervical Cancer Screening - Persistent HPV Infections and Squamous Cell Lesions: Evaluation of over 10000 Patients Registerstudie der Arbeitsgemeinschaft Zervixpathologie und Kolposkopie e. V. (AGCPC) zum Abkl"rungsalgorithmus im neuen Zervixkarzinomscreening - HPV-Persistenz und plattenepitheliale L"sionen: Evaluation von über 10000 Patientinnen (2026) Henes M, Mann E, Hirchenhain C, Kentner A, Selgrad C, Hampl M, Keyver-Paik MD, et al. Journal article Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer (2026) Ji Y, Wang C, Combes FP, Ho YY, Fasching PA, Untch M, Zarate JP, Crown J Journal article Inhibiting NHEJ in HNSCC cell lines by the ligase IV inhibitor SCR130 has limited radiosensitizing effects (2025) Hildebrand L, Jost T, Schindler M, Derer A, Fuhrmann G, Fietkau R, Distel L Journal article